Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry.
Huilgol YS, Keane H, Shieh Y, Hiatt RA, Tice JA, Madlensky L, Sabacan L, Fiscalini AS, Ziv E, Acerbi I, Che M, Anton-Culver H, Borowsky AD, Hunt S, Naeim A, Parker BA, van 't Veer LJ; Athena Breast Health Network Investigators and Advocate Partners; Esserman LJ. Huilgol YS, et al. Among authors: madlensky l. NPJ Breast Cancer. 2021 Aug 3;7(1):102. doi: 10.1038/s41523-021-00306-9. NPJ Breast Cancer. 2021. PMID: 34344894 Free PMC article.
The WISDOM study: a new approach to screening can and should be tested.
Esserman L, Eklund M, Veer LV, Shieh Y, Tice J, Ziv E, Blanco A, Kaplan C, Hiatt R, Fiscalini AS, Yau C, Scheuner M, Naeim A, Wenger N, Lee V, Heditsian D, Brain S, Parker BA, LaCroix AZ, Madlensky L, Hogarth M, Borowsky A, Anton-Culver H, Kaster A, Olopade OI, Sheth D, Garcia A, Lancaster R, Plaza M. Esserman L, et al. Among authors: madlensky l. Breast Cancer Res Treat. 2021 Oct;189(3):593-598. doi: 10.1007/s10549-021-06346-w. Epub 2021 Sep 16. Breast Cancer Res Treat. 2021. PMID: 34529196 No abstract available.
Implementing a Population-Based Breast Cancer Risk Assessment Program.
Silver E, Wenger N, Xie Z, Elashoff D, Lee K, Madlensky L, Trent J, Petruse A, Johansen L, Naeim A. Silver E, et al. Among authors: madlensky l. Clin Breast Cancer. 2019 Aug;19(4):246-253.e2. doi: 10.1016/j.clbc.2019.02.009. Epub 2019 Mar 11. Clin Breast Cancer. 2019. PMID: 31072694 Free article.
An Antiestrogenic Activity Score for tamoxifen and its metabolites is associated with breast cancer outcome.
de Vries Schultink AH, Alexi X, van Werkhoven E, Madlensky L, Natarajan L, Flatt SW, Zwart W, Linn SC, Parker BA, Wu AH, Pierce JP, Huitema AD, Beijnen JH. de Vries Schultink AH, et al. Among authors: madlensky l. Breast Cancer Res Treat. 2017 Feb;161(3):567-574. doi: 10.1007/s10549-016-4083-6. Epub 2016 Dec 22. Breast Cancer Res Treat. 2017. PMID: 28005246 Free PMC article.
Tamoxifen metabolite concentrations, CYP2D6 genotype, and breast cancer outcomes.
Madlensky L, Natarajan L, Tchu S, Pu M, Mortimer J, Flatt SW, Nikoloff DM, Hillman G, Fontecha MR, Lawrence HJ, Parker BA, Wu AH, Pierce JP. Madlensky L, et al. Clin Pharmacol Ther. 2011 May;89(5):718-25. doi: 10.1038/clpt.2011.32. Epub 2011 Mar 23. Clin Pharmacol Ther. 2011. PMID: 21430657 Free PMC article.
Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial.
Pierce JP, Natarajan L, Caan BJ, Parker BA, Greenberg ER, Flatt SW, Rock CL, Kealey S, Al-Delaimy WK, Bardwell WA, Carlson RW, Emond JA, Faerber S, Gold EB, Hajek RA, Hollenbach K, Jones LA, Karanja N, Madlensky L, Marshall J, Newman VA, Ritenbaugh C, Thomson CA, Wasserman L, Stefanick ML. Pierce JP, et al. Among authors: madlensky l. JAMA. 2007 Jul 18;298(3):289-98. doi: 10.1001/jama.298.3.289. JAMA. 2007. PMID: 17635889 Free PMC article. Clinical Trial.
94 results